JAZZ FY 2022 Earnings — Jazz Pharmaceuticals plc Revenue & Financial Results | Market Cap Arena

JAZZJazz Pharmaceuticals plc

$12B

FY 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$3.7B+18.3% YoY

Gross Profit

$3.1B85.2% margin

Operating Income

-$66M-1.8% margin

Net Income

-$224M-6.1% margin

EPS (Diluted)

$-3.58

Cash Flow

Operating Cash Flow

$1.3B

Free Cash Flow

$774M

Stock-Based Comp.

$222M

Balance Sheet

Total Assets

$10.8B

Total Liabilities

$7.7B

Stockholders' Equity

$3.1B

Cash & Equivalents

$881M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$3.7B	$3.1B	+18.3%
Gross Profit	$3.1B	$2.7B	+17.5%
Operating Income	-$66M	$170M	-138.5%
Net Income	-$224M	-$329M	+31.9%